Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Granulocyte transfusions in the G-CSF era. Where do we stand?

Bone Marrow Transplantation volume 34, pages 839–846 (2004)Cite this article

Summary:

The efficacy of granulocytes transfusions (GTX) in either the prevention or treatment of neutropenic sepsis has been a controversial issue. Early studies employing steroid mobilised GTX showed variable, dose-dependent results and significant pulmonary toxicity was reported. With the introduction of the recombinant myeloid growth factor, granulocyte-colony stimulating factor (G-CSF), the quantity of granulocytes that could be harvested was substantially increased leading to renewed interest in the clinical application of GTX. The administration of G-CSF to normal donors leads to significantly higher pre-harvest neutrophil counts and consequently larger granulocyte harvests. Infusion of G-CSF stimulated GTX results in measurable increases in the recipients' neutrophil count and may reduce the duration and severity of neutropenia. However, the efficacy of these GTX in treating or preventing established neutropenic sepsis remains to be established in prospective controlled clinical trials.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Williamson E, Millar M, Steward C et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560–568.

    Article  CAS  PubMed  Google Scholar 

  2. Mitchell A, Derrington P, Tumer P et al. Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome. Bone Marrow Transplant 2004; 33: 303–310.

    Article  CAS  PubMed  Google Scholar 

  3. Strumia MM . The effect of leukocyte cream injections in the treatment of neutropenias. Am J Med Sci 1934; 187: 527–544.

    Article  Google Scholar 

  4. Brecher G, Wilbur KM, Kronkite EP . Transfusion of separated leukocytes into irradiated dogs with aplastic marrows. Proc Soc Exp Biol Med 1953; 84: 54–56.

    Article  CAS  PubMed  Google Scholar 

  5. Appelbaum FR, Bowles CA, Makuch RW et al. Granulocyte transfusion therapy of experimental Pseudomonas septicaemia: study of cell dose and collection technique. Blood 1978; 52: 323–331.

    CAS  PubMed  Google Scholar 

  6. Strauss RG . Therapeutic granulocyte transfusions in 1993. Blood 1991; 81: 1675–1678.

    Google Scholar 

  7. Freireich EJ, Judson G, Levin RH . Separation and collection of leukocytes. Cancer Res 1965; 25: 1516–1520.

    CAS  PubMed  Google Scholar 

  8. Yankee RA, Freireich EJ, Carbonne PP et al. Replacement therapy using normal and chronic myelogenous leukaemia leukocytes. Blood 1964; 24: 844–845.

    Google Scholar 

  9. Mishler JM . New dosage regimens for HES during intensive leukapheresis. Transfusion 1978; 18: 126.

    Article  PubMed  Google Scholar 

  10. McCredie KB, Freireich EJ, Hester JP et al. Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch. Transfusion 1974; 14: 357–364.

    Article  CAS  PubMed  Google Scholar 

  11. Winton EF, Vogler WR . Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with the continuous-flow centrifugal blood cell separator. Blood 1978; 52: 249–253.

    CAS  PubMed  Google Scholar 

  12. Buckner D, Graw RG, Eisel RJ et al. Leukapheresis by continuous flow centrifugation in patients with chronic myelocytic leukemia. Blood 1969; 33: 353–369.

    CAS  PubMed  Google Scholar 

  13. Herzig RH, Herzig GP, Graw RG et al. Successful granulocyte transfusion therapy for gram-negative septicemia. N Engl J Med 1977; 296: 701–705.

    Article  CAS  PubMed  Google Scholar 

  14. Higby DJ, Yates JW, Henderson ES et al. Filtration lekapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med 1975; 292: 761–766.

    Article  CAS  PubMed  Google Scholar 

  15. Vogler WR, Winton EF . A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977; 63: 548–555.

    Article  CAS  PubMed  Google Scholar 

  16. Fortuny IE, Bloomfield CD, Hadlock DC et al. Granulocyte transfusion: a controlled study in patients with acute non-lymphocytic leukemia. Transfusion 1975; 15: 548–558.

    Article  CAS  PubMed  Google Scholar 

  17. Winston DJ, Ho WG, Gale WP . Therapeutic granulocyte transfusions for documented infections: a controlled trial in 95 infectious granulocytopenic episodes. Ann Intern Med 1982; 97: 509–515.

    Article  CAS  PubMed  Google Scholar 

  18. Han P, Vincent PC . Problems with filtration-collected neutrophils. N Engl J Med 1976; 294: 729.

    CAS  PubMed  Google Scholar 

  19. Wright DG, Robichaud KJ, Pizzo PA et al. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981; 304: 1185–1189.

    Article  CAS  PubMed  Google Scholar 

  20. Wright DG, Kauffmann JC, Chusid MJ et al. Functional abnormalities of human neutrophils collected by continuous flow filtration leucopheresis. Blood 1975; 46: 901–911.

    CAS  PubMed  Google Scholar 

  21. Winton EF, Vogler WR . Development of a practical oral dexamethasone premedication schedule leading to improved granulocyte yields with continuous-flow centrifugal blood cell separator. Blood 1978; 28: 249–253.

    Google Scholar 

  22. Liles WC, Huang JE, Llewellyn D et al. A comparative trial of granulocyte-colony-stimulating factor, separately and in combination, for the mobilisation of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997; 37: 182–187.

    Article  CAS  PubMed  Google Scholar 

  23. Jendiroba DB, Lichtiger B, Anaissie E et al. Evaluation and comparison of three mobilisation methods for the collection of granulocytes. Transfusion 1998; 38: 722–728.

    Article  CAS  PubMed  Google Scholar 

  24. Demetri GD, Griffin JD . The role of granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791–2808.

    CAS  PubMed  Google Scholar 

  25. Chatta GS, Price TH, Allen RC et al. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994; 84: 2923–2929.

    CAS  PubMed  Google Scholar 

  26. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883–1888.

    CAS  PubMed  Google Scholar 

  27. Liles WC, Rodger E, Dale DC . Combined administration of G-CSF and dexamethasone for the mobilisation of granulocytes in normal donors: optimisation of dosing. Transfusion 2000; 40: 642–644.

    Article  CAS  PubMed  Google Scholar 

  28. Caspar CB, Seger RA, Burger J et al. Effective stimulation of donors for granulocyte transfusions with methionyl granulocyte colony-stimulating factor. Blood 1993; 81: 2866–2871.

    CAS  PubMed  Google Scholar 

  29. Dale DC, Liles WC, Llewellyn C et al. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion 1998; 38: 713–721.

    Article  CAS  PubMed  Google Scholar 

  30. Leavey PJ, Thurman G, Ambruso DR . Functional characteristics of neutrophils collected and stored after administration of G-CSF. Transfusion 2000; 40: 414–419.

    Article  CAS  PubMed  Google Scholar 

  31. Lee JJ, Cheung IJ, Park MR et al. Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukaemia 2001; 15: 203–207.

    Article  CAS  Google Scholar 

  32. Adkins DR, Spitzer G, Johnston M et al. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997; 37: 737–748.

    Article  CAS  PubMed  Google Scholar 

  33. Adkins DR, Goodnough LT, Shenoy S et al. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000; 95: 3602–3612.

    Google Scholar 

  34. Hubel K, Carter RA, Liles C et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community vs related donors. Transfusion 2002; 42: 1414–1421.

    Article  PubMed  Google Scholar 

  35. Stroncek DF, Matthews CL, Follman D et al. Kinetics of G-CSF-induced granulocyte mobilisation in healthy subjects: effects of route of administration and addition of dexamethasone. Transfusion 2002; 42: 597–602.

    Article  CAS  PubMed  Google Scholar 

  36. Leitman SF, Yu M, Lekstrom J . Pair controlled study of granulocyte colony stimulating factor (G-CSF) for granulocytapheresis donors. Transfusion 1995; 35 (Suppl): 53S (abstract).

    Google Scholar 

  37. Glasser L, Fiederlein RL, Huestis DW . Liquid preservation of human neutrophils stored in synthetic media at 22°C: controlled observations on storage variables. Blood 1985; 66: 267.

    CAS  PubMed  Google Scholar 

  38. American Association of Blood Banks. AABB Technical Manual, 14th edn. American Association of Blood Banks: MD, USA, 2002.

  39. Council of Europe. Council of Europe Guide to the Preparation, Use and Quality Assurance of Blood Components, 9th edn. Council of Europe Publishing: Strasbourg, France, 2003.

  40. Hubel K, Dale DC, Rodger E et al. Preservation of function in granulocyte concentrates collected from donors stimulated with G-CSF/dexamethasone during storage at reduced temperature. Blood 2000; 96: 820a.

    Google Scholar 

  41. McCullough J, Clay M, Herr G et al. Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors. Transfusion 1999; 39: 1136–1140.

    Article  CAS  PubMed  Google Scholar 

  42. Ghodsi Z, Strauss RG . Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion 2001; 41: 1464–1468.

    Article  CAS  PubMed  Google Scholar 

  43. Stroncek DF, Clay ME, Herr G et al. Blood counts in healthy donors 1 year after the collection of granulocyte colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 1997; 37: 304–308.

    Article  CAS  PubMed  Google Scholar 

  44. Cavallaro AM, Lilleby K, Majolino I et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000; 25: 85–89.

    Article  CAS  PubMed  Google Scholar 

  45. Price TH, Bowden RA, Boeckh M et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for the treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000; 95: 3302–3309.

    CAS  PubMed  Google Scholar 

  46. Narvios A, Pena E, Xiang-Yang H et al. Cytomegalovirus infections in cancer patients receiving granulocyte transfusions. Blood 2002; 99: 390–391 (Letter).

    Article  CAS  PubMed  Google Scholar 

  47. Vij R, DiPersio JF, Venkatraman P et al. Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. Blood 2003; 101: 2067–2069.

    Article  CAS  PubMed  Google Scholar 

  48. Nichols GW, Price T, Boeckh M . Cytomegalovirus infections in cancer patients receiving granulocyte transfusions. Blood 2002; 99: 2483–3484 (Letter).

    Article  Google Scholar 

  49. Nichols GW, Price T, Boeckh M . Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions. Blood 2003; 101: 5091–5092 (Letter).

    Article  CAS  PubMed  Google Scholar 

  50. Peters C, Minkov M, Matthes-Martin S et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 1999; 106: 689–696.

    Article  CAS  PubMed  Google Scholar 

  51. Illerhaus G, Wirth K, Dwenger A et al. Treatment and prophylaxis of severe infections in neutropenic infections by granulocyte transfusions. Ann Hematol 2002; 81: 273–281.

    Article  CAS  PubMed  Google Scholar 

  52. Rutella S, Pierelli L, Sica S et al. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors. Cytotherapy 2003; 5: 19–30.

    Article  CAS  PubMed  Google Scholar 

  53. Cesaro S, Chinello P, De Silvestro G et al. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer 2003; 11: 101–106.

    Article  PubMed  Google Scholar 

  54. Grigull L, Schrauder A, Schmitt-Thomssen A et al. Efficacy and safety of G-CSF mobilised granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infections. Infection 2002; 30: 267–271.

    Article  CAS  PubMed  Google Scholar 

  55. Adkins D, Goodnough LT, Moellering J et al. Reduction in antibiotic utilization and if febrile days by transfusion of G-CSF mobilised prophylactic granulocyte components: a randomised study. Blood 1999; 94: 590a.

    Google Scholar 

  56. Blum W, Hallem C, Vij R et al. Improved survival in allogeneic peripheral blood stem cell (PBSC) transplant patients who received prophylactic granulocyte transfusions from HLA-matched donors: long term follow-up. Blood 2001; 98: 58a.

    Google Scholar 

  57. Kerr PJ, Liakopolou E, Brown J et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol 2003; 123: 114–118.

    Article  PubMed  Google Scholar 

  58. Goldstein IM, Eyre HJ, Terasaki PI et al. Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusions 1971; 11: 19–24.

    Article  CAS  Google Scholar 

  59. Graw RG, Eyre HJ, Goldstein IM et al. Histocompatibility testing for leucocyte transfusion. Lancet 1970; 1: 77–78.

    Article  PubMed  Google Scholar 

  60. Westrick MA, Debelak-Fehir KM, Epstein RB . The effect of prior whole blood transfusion on subsequent support in leukopenic dogs. Transfusion 1977; 17: 611–614.

    Article  CAS  PubMed  Google Scholar 

  61. McCullough J, Weiblen BJ, Clay ME et al. Effect of leukocyte antibodies on the fate in vivo of indium-111-labelled granulocytes. Blood 1981; 58: 164–170.

    CAS  PubMed  Google Scholar 

  62. Stroncek DF, Leonard K, Eiber HL et al. Alloimmunisation after granulocyte transfusions. Transfusion 1996; 36: 1009–1015.

    Article  CAS  PubMed  Google Scholar 

  63. Dutcher JP, Schiffer CA, Johnston GS et al. Alloimmunisation prevents the migration of transfused indium-111-labelled granulocytes to sites of infection. Blood 1983; 62: 354–360.

    CAS  PubMed  Google Scholar 

  64. Appelbaum FR, Trapani RJ, Graw Jr RG . Consequences of prior alloimmunisation during granulocyte transfusion. Transfusion 1977; 17: 460–464.

    Article  CAS  PubMed  Google Scholar 

  65. Boggs DR . Transfusion of neutrophils as prevention or treatment of infection in patients with neutropenia. N Engl J Med 1974; 290: 1055–1062.

    Article  CAS  PubMed  Google Scholar 

  66. Watanabe C, Yajima S, Taguchi T et al. Successful unrelated bone marrow trasplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant 2001; 28: 83–87.

    Article  CAS  PubMed  Google Scholar 

  67. Bielorai B, Toren A, Wolach B et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 26: 1025–1028.

    Article  CAS  PubMed  Google Scholar 

  68. Dale DC . Renewed interest in granulocyte transfusion therapy. Br J Haematol 1997; 98: 497–501.

    Article  CAS  PubMed  Google Scholar 

  69. Winston DJ, Ho WG, Young LS et al. Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 1980; 68: 893–897.

    Article  CAS  PubMed  Google Scholar 

  70. Strauss RG, Connett JE, Gale RP et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukaemia. N Engl J Med 1981; 305: 597–603.

    Article  CAS  PubMed  Google Scholar 

  71. Winston DJ, Ho WG, Gale RP . Prophylactic granulocyte transfusions during chemotherapy for acute nonlymphocytic leukemia. Ann Int Med 1981; 94: 616–622.

    Article  CAS  PubMed  Google Scholar 

  72. Ford JM, Cullen MH, Roberts MM et al. Prophylactic granulocyte transfusions:results of a randomised controlled trial in patients with acute myelogenous leukemia. Transfusion 1982; 22: 311–316.

    Article  CAS  PubMed  Google Scholar 

  73. Vamvakas EC, Pineda AA . Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apheresis 1997; 12: 74–81.

    Article  CAS  PubMed  Google Scholar 

  74. Herman S, Klein SA, Jacobi V et al. Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens. Br J Haematol 2000; 113: 446–454.

    Article  Google Scholar 

  75. Ascioglu S, Rex JH . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.

    Article  CAS  PubMed  Google Scholar 

  76. Sachs UJ, Bux J . TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 2003; 43: 1683–1686.

    Article  PubMed  Google Scholar 

  77. Schiffer CA, Aisner J, Daly PA et al. Alloimmunisation following prophylactic granulocyte transfusion. Blood 1979; 54: 766–774.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol Royal Children's Hospital, Bristol, UK

    S P Robinson & D I Marks

Authors
  1. S P Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D I Marks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S P Robinson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, S., Marks, D. Granulocyte transfusions in the G-CSF era. Where do we stand?. Bone Marrow Transplant 34, 839–846 (2004). https://doi.org/10.1038/sj.bmt.1704630

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704630

Keywords

This article is cited by

Search

Advanced search

Quick links